Biological
Measles, mumps, rubella, varicella vaccine clinical trials
- studies test it
- 14
- open now
- 0
- in phase 3
- 10
- first study started
- 1998
How studies write it
Studies that test it under each name
Studies by the year they started
14 studies that test it; most in 2000 (3)
| Year | Studies |
|---|---|
| 1998 | 1 |
| 1999 | 1 |
| 2000 | 3 |
| 2006 | 3 |
| 2007 | 3 |
| 2008 | 1 |
| 2012 | 1 |
| 2015 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 2
- 1
- Phase 3
- 10
- Phase 4
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 13 · Other 1
Merck Sharp & Dohme LLC (12) · GlaxoSmithKline (1) · Medical University of South Carolina (1)
Often tested with
Tested in the same studies.
Measles-Mumps-Rubella Vaccine (1) · Diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine (1) · Hepatitis A Vaccines (1) · Heptavalent Pneumococcal Conjugate Vaccine (1)
Studies
Open first, then newest update. How each study uses measles, mumps, rubella, varicella vaccine is read from its arms, and is right about nine times in ten.
Testing it · 14
- Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of AgeCompletedPhase 3GlaxoSmithKlineNCT01621802Written as ProQuad
- Safety and Efficacy of ProQuad® in Children 6-24 Month Being Evaluated for Solid Organ TransplantCompletedEarly Phase 1Medical University of South CarolinaNCT02687763Written as ProQuad
- Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED)CompletedPhase 4Merck Sharp & Dohme LLCNCT00326183Written as ProQuad
- ProQuad® Intramuscular vs SubcutaneousCompletedPhase 3Merck Sharp & Dohme LLCNCT00402831Written as ProQuad®
- Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035)CompletedPhase 3Merck Sharp & Dohme LLCNCT00432042Written as ProQuad®
- Safety Study of ProQuad® rHA in Infants (V221-037)CompletedPhase 3Merck Sharp & Dohme LLCNCT00560755Written as ProQuad®
- Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month-Old Children (V251-067)CompletedPhase 4Merck Sharp & Dohme LLCNCT00312858Written as Comparator: ProQuad™ (Measles, Mumps, Rubella and Varicella vaccine)
- V221 Concomitant Use Study With Pneumococcal Conjugate Vaccine (V221-019)CompletedPhase 3Merck Sharp & Dohme LLCNCT00109343Written as Comparator: ProQuad™ (V221)
- A Study of ProQuad™ in Healthy Children in Korea (V221-023)TerminatedPhase 3Merck Sharp & Dohme LLCNCT00839917Written as Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (ProQuad™)
- Safety, Tolerability, and Immunogenicity of 3 Frozen ProQuad Consistency Lots in Healthy Children (V221-012)(COMPLETED)CompletedPhase 3Merck Sharp & Dohme LLCNCT00985153Written as Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live
- ProQuad™ Versus M-M-R II™ and VARIVAX™ in Healthy Children (V221-009)(COMPLETED)CompletedPhase 3Merck Sharp & Dohme LLCNCT00975507Written as Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live
- Frozen ProQuad Administered Concomitantly Versus Nonconcomitantly With Other Pediatric VaccinesCompletedPhase 3Merck Sharp & Dohme LLCNCT00984295Written as Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live
- A Study of ProQuad in Healthy 4 to 6 Year Old Children (V221-014)CompletedPhase 3Merck Sharp & Dohme LLCNCT00985166Written as ProQuad (Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live)
- ProQuad Dose Selection Study (V221-011)(COMPLETED)CompletedPhase 2Merck Sharp & Dohme LLCNCT00986232Written as Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live
Given in every arm · 1 — measles, mumps, rubella, varicella vaccine is usual care beside what is tested
As the comparator · 5 — what is tested is compared with measles, mumps, rubella, varicella vaccine
- A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Given to Healthy Children 4 to 6 Years of AgeNot yet recruitingPhase 3GlaxoSmithKlineNCT07742644Written as MMRV vaccine
- A Study on the Immune Response and Safety of a Combined Measles, Mumps, Rubella, Chickenpox Vaccine Compared to a Marketed Combined Vaccine, Given to Healthy Children 4 to 6 Years of AgeCompletedPhase 2GlaxoSmithKlineNCT05630846Written as Marketed MMRV_Lot 1 and Lot 2 vaccine
- Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027)CompletedPhase 3Merck Sharp & Dohme LLCNCT01536405Written as MMRV (2006 process)
- Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of AgeCompletedPhase 2GlaxoSmithKlineNCT00578175Written as ProQuad®
- Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy ToddlersCompletedPhase 3Sanofi Pasteur, a Sanofi CompanyNCT00422292Written as Measles, Mumps, Rubella and Varicella